Risk Factor for Progression of Microalbuminuria in Relatively Young NIDDM-Patients

  • Ryuichi Kikkawa
  • Masakazu Haneda


Microalbuminuria, which is defined as a minute increase in urinary albumin excretion rate in patients whose urine is Albustix-negative, is reported the most reliable predictor for the development of clinical diabetic nephropathy in IDDM [1,2]. Similarly to findings in IDDM, the pioneering work by Mogensen has clearly showed that, in NIDDM, the incidence of macroalbuminuria or of clinical proteinuria of a 9-year period is higher in those with microalbuminuria (22%) than in those with normoalbuminuria (5%) [3], although the predictive power of microalbuminuria appeared to be lower in patients with NIDDM. Since microalbuminuria can reportedly predict the risk of early mortality as well as of clinical proteinuria in subjects with NIDDM [3], it is important to identify the factor(s) responsible for the development and progression of microalbuminuria. Although it may be worthwhile to investigate the progression of microalbuminuria in relatively young subjects with NIDDM, who would be expected to live long enough to show the outcome of microalbuminuria perhaps by minimizing the influence of age-related cardiovascular diseases, the mean age of such subjects studied is in the late 50s. In this chapter, we will summarize the data obtained in such patients with NIDDM.


Diabetic Nephropathy Atrial Natriuretic Peptide Albumin Excretion Rate Mean Blood Pressure Urinary Albumin Excretion Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430–1432.PubMedCrossRefGoogle Scholar
  2. 2.
    Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93.PubMedCrossRefGoogle Scholar
  3. 3.
    Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356–360.PubMedCrossRefGoogle Scholar
  4. 4.
    Kikkawa R, Haneda M, Togawa M, Koya D, Ebata K, Arimura T, Maeda S, Shigeta Y. Microalbuminuria associated with a rise in blood pressure in non-insulin-dependent diabetes. J Diabetic Complications 1989; 3: 99–102.CrossRefGoogle Scholar
  5. 5.
    Schmitz A, Vaeth M. Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Med 1988; 5: 126–134.PubMedCrossRefGoogle Scholar
  6. 6.
    Luetscher JA, Kraemer FB. Microalbuminuria and increased plasma prorenin. Prevalence in diabetics followed up for four years. Arch Intern Med 1988; 148: 937–941.PubMedCrossRefGoogle Scholar
  7. 7.
    Gall M-A, Rossing P, Skett P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougaard P, Beck-Nielsen H, Parving H-H. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655–661.PubMedCrossRefGoogle Scholar
  8. 8.
    Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736–741.PubMedCrossRefGoogle Scholar
  9. 9.
    Haffner SM, Mitchell BD, Pugh JA, Stern MP, Kozlowski MK, Hazuda HP, Patterson JK, Klein R. Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care 1989; 12: 530–536.PubMedCrossRefGoogle Scholar
  10. 10.
    Uusitupa M, Stitonen O, Penttiä I, Aro A, Pyörälä K. Proteinuria in newly diagnosed type II diabetic patients. Diabetes Care 1987; 10: 191–194.PubMedCrossRefGoogle Scholar
  11. 11.
    Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987; 31: 673–689.PubMedCrossRefGoogle Scholar
  12. 12.
    Cooper MN, Frauman A, O’Brien RC, Seeman E, Murray RML, Jerums G. Progression of proteinuria in type 1 and type 2 diabetes. Diabetic Med 1988; 5: 361–368.PubMedCrossRefGoogle Scholar
  13. 13.
    Haneda M, Kikkawa R, Togawa M, Koya D, Kajiwara N, Uzu T, Shigeta Y. High blood pressure is a risk factor for the development of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes mellitus. J Diabetic Complications 1992; 6: 181–185.CrossRefGoogle Scholar
  14. 14.
    Shigeta Y, Haneda M, Kikkawa R. Clinical significance of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes. J Diabetic Complications 1991; 5: 84–86.CrossRefGoogle Scholar
  15. 15.
    Reichard P, Nilsson B-Y, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304–309.PubMedCrossRefGoogle Scholar
  16. 16.
    Ballard DJ, Humphrey LL, Melton LJ III, Frohnert PP, Chu C-P, O’Fallon WM, Palumbo PJ. Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 1988; 37: 405–412.PubMedCrossRefGoogle Scholar
  17. 17.
    Jerums G, Cooper ME, Seeman E, Murray RML, McNeil JJ. Spectrum of proteinuria in type I and type II diabetes. Diabetes Care 1987; 10: 419–427.PubMedCrossRefGoogle Scholar
  18. 18.
    Knowler WC, Bennett PH, Nelson RG, Prediabetic blood pressure predicts albuminuria after development of NIDDM. Diabetes 1988; 37: suppl. 1: 120A.Google Scholar
  19. 19.
    Kunzelman CL, Knowler WC, Pettitt DJ, Bennett PH. Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney Int 1989; 35: 681–687.PubMedCrossRefGoogle Scholar
  20. 20.
    Ravid M, Savin H, Lang R, Jutrin I, Shoshana L, Lishner M. Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. Arch Intern Med 1992; 152: 1225–1229.PubMedCrossRefGoogle Scholar
  21. 21.
    Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. BMJ 1987; 295: 515–517.PubMedCrossRefGoogle Scholar
  22. 22.
    Krolewski AS, Canessa M, Warram JH, Laffel LMB, Christlieb AR, Knowler WC, Rand LI. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 140–145.PubMedCrossRefGoogle Scholar
  23. 23.
    Gall M-A, Rossing P, Jensen JS, Funder J, Parving H-H. Red cell Na+/Li + countertransport in non-insulin-dependent diabetics with diabetic nephropathy. Kidney Int 1991; 39: 135–140.PubMedCrossRefGoogle Scholar
  24. 24.
    Kikkawa R, Araki S, Haneda M, Kajiwara N, Hidaka H, Shigeta Y. Hypertension and the development of complications in patients with non-insulin-dependent diabetes mellitus in Japan. J Am Soc Nephrol 1992; 3: S120–S125.Google Scholar
  25. 25.
    Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 438–443.PubMedCrossRefGoogle Scholar
  26. 26.
    Mathiesen ER, Oxenb0ll B, Johansen K, Svendsen PAa, Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984; 26: 406–410.PubMedCrossRefGoogle Scholar
  27. 27.
    Shinoda T, Ishihara M, Kurimoto F, Aizawa T, Hiramatsu K, Shirota T, Takasu N, Yamada T. Elevated plasma atrial natriuretic peptide level in the early phase of microalbuminuria in patients with non-insulin-dependent diabetes mellitus. Clin Nephrol 1990; 34: 202–207.PubMedGoogle Scholar
  28. 28.
    Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, den Otto lander GJH. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319–323.PubMedCrossRefGoogle Scholar
  29. 29.
    Murakami T, Komiyama Y, Egawa H, Murata K. Elevation of factor Xla-a,-antitrypsin complex levels in NIDDM patients with diabetic nephropathy. Diabetes 1993; 42: 233–238.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Ryuichi Kikkawa
  • Masakazu Haneda

There are no affiliations available

Personalised recommendations